I disagree, although I have only been invested for a week or...

I disagree, although I have only been invested for a week or two.

The company has only recently appointed a US distributor. Obviously they need to be trained up on the product before they can go out and sell it, and that is smack bang in the middle of the biggest medical emergency in a couple of generations which has shut down some surgery completely. If I was a surgeon, the last place I would likely want to be is a hospital! However, they have an established track record of successful procedures, approvals in many markets globally, with more distribution partners hopefully not too far away. That being the case I would argue that when the covid situation calms down, these guys should be able to start selling more volume.

Higher risk, higher return I guess. The thing I like is that if you believe they can sell the product, then there is a great MOAT around their business in terms of any competitors need approvals and as an incumbent in a market such as this it is very hard for a new player to enter, unless they have a superior product. That can protect and enhance revenues.

Anyway... DWMS2U